3D Printed and Nanofabricated Scaffolds for Engineering Contractile Cardiac Muscle
Dr. Adam Feinberg
Regenerative Biomaterials and Therapeutics Group, Carnegie Mellon University, USA
Dr. Feinberg is the principal investigator of the Regenerative Biomaterials and Therapeutics Group and an Associate Professor at Carnegie Mellon University. He earned his BS in Materials Science and Engineering from Cornell University in 1999 with Co-op experience at Abiomed, Inc., working on total artificial hearts. He then earned MS and PhD degrees in Biomedical Engineering from the University of Florida, focused on engineering cell-material interactions to prevent and enhance adhesion. This was followed by postdoctoral training at Harvard University, developing new biomaterials and stem cell-based cardiac tissue engineering strategies. He joined the faculty at Carnegie Mellon in the fall of 2010 with joint appointments in Biomedical Engineering and Materials Science and Engineering. Dr. Feinberg has co-authored over 30 peer-reviewed publications and holds 15 US patents and patent applications. He has also been awarded the NSF CAREER Award, the NIH Director’s New Innovator Award, and the American Heart Association Scientist Development Grant. Current research is focused on biomimetic strategies to fabricate ECM protein-based materials from fibronectin, laminin, and collagens type I and IV to build 2D and 3D scaffolds for corneal and cardiac tissue engineering. Further, he is working to understand the biomechanics and mechanobiology of these engineered ECM protein materials, specifically how strain modulates biological activity.